TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Infectious Disease
Division of General Internal Medicine
更新時間：2024-06-04
張上淳Chang, Shan-Chwen
- Principal Investigator
- Clinical Trial Experience (year) 23 years 9 個月
-
ntuvpmed@ntu.edu.tw
Publication
61Publications
1
Sheng WH, Liu WD, Wang JT, Chang SY, Chang SC. Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan. J Formos Med Assoc. 2021 Jan;120(1 Pt 2):311-317. doi: 10.1016/j.jfma.2020.10.003. Epub 2020 Oct 20. PMID: 33139151; PMCID: PMC7574720.
2
Huang YS, Tsai WC, Li JJ, Chen PY, Wang JT, Chen YT, Chen FJ, Lauderdale TL, Chang SC. Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018. Sci Rep. 2021 Jan 28;11(1):2609. doi: 10.1038/s41598-021-82166-8. PMID: 33510280; PMCID: PMC7843600.
3
Yuan CT, Wang JT, Sheng WH, Cheng PY, Kao CJ, Wang JY, Chen CY, Liau JY, Tsai JH, Lin YJ, Chen CC, Chen YC, Chang SC, Wu UI. Lymphadenopathy Associated With Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable From Malignant Lymphoma and Treatable by Antibiotics: A Clinicopathologic Study. Am J Surg Pathol. 2021 Aug 1;45(8):1138-1150. doi: 10.1097/PAS.0000000000001731. PMID: 34010155.
4
Liu WD, Chang SY, Lan TY, Lin YC, Kao JH, Liao CH, Tsai MJ, Kuo PH, Huang YS, Wang JT, Sheng WH, Hsieh SC, Chiang BL, Chen YC, Chang SC. Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics. J Formos Med Assoc. 2021 May;120(5):1269-1273. doi: 10.1016/j.jfma.2020.08.022. Epub 2020 Aug 25. PMID: 32888840; PMCID: PMC7447255.
5
Huang TT, Chien YC, Wang CH, Chang SY, Wang JT, Hsieh SC, Yeh YC, Ku SC, Yu CJ, Chiang BL, Chang SC, Tolwani A. Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report. Front Med (Lausanne). 2021 Jun 7;8:649583. doi: 10.3389/fmed.2021.649583. PMID: 34164411; PMCID: PMC8215202.
6
Lin KY, Yang CJ, Sun HY, Chuang YC, Chang LH, Liu WC, Su YC, Chang SY, Hung CC, Chang SC. Comparisons of Serologic Responses of Early Syphilis to Treatment with a Single-Dose Benzathine Penicillin G Between HIV-Positive and HIV-Negative Patients. Infect Dis Ther. 2021 Sep;10(3):1287-1298. doi: 10.1007/s40121-021-00450-6. Epub 2021 May 4. PMID: 33948910; PMCID: PMC8322187.
7
Huang SH, Huang WC, Lin SW, Chuang YC, Sun HY, Chang SY, Kuo PH, Wu PY, Liu WC, Chiang C, Hung CC, Chang SC. Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV. J Acquir Immune Defic Syndr. 2021 Jun 1;87(2):834-841. doi: 10.1097/QAI.0000000000002650. PMID: 33587507.
8
Hsieh SM, Pan SC, Huang YS, Chang SC. Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study. J Acquir Immune Defic Syndr. 2021 Apr 1;86(4):500-508. doi: 10.1097/QAI.0000000000002577. PMID: 33620177.
9
Huang CF, Hsieh SM, Pan SC, Huang YS, Chang SC. Dose-Related Aberrant Inhibition of Intracellular Perforin Expression by S1 Subunit of Spike Glycoprotein That Contains Receptor-Binding Domain from SARS-CoV-2. Microorganisms. 2021 Jun 15;9(6):1303. doi: 10.3390/microorganisms9061303. PMID: 34203929; PMCID: PMC8232787.
10
Pan SC, Huang YS, Hsieh SM, Chen YC, Chang SY, Chang SC. A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan. J Formos Med Assoc. 2021 Jul;120(7):1459-1463. doi: 10.1016/j.jfma.2021.01.002. Epub 2021 Jan 9. PMID: 33461841; PMCID: PMC7833685.
